As recent technological advancements have spurred the transition of traditional trades into the virtual realm, more and more businesses are shedding the conventional confines of how things ‘should’ be done in-person, instead working toward how they can be done better online. As the past year and half’s covid-19 pandemic massively expanded the demand for virtual accessibility, key innovators across a number of industries have made game-changing inroads into the world of online services.
One such industry emerging from this increased societal demand has undoubtedly been the healthcare sector, as amplified health concerns have caused people to search for new formats of medical care unlike ever experienced before. Now, novel telehealth services have arrived to provide near-immediate virtual service with pharmaceutical shipment directly to consumers’ doorsteps, shirking the restraints of COVID-19’s social distancing regulations and allowing people from the farthest corners of the United States to benefit from this revolutionary shift. Today we explore two of the most innovative and up-and-coming leaders in the healthcare space, leading by example on how to improve society’s access to quality care in our day to day lives.
These days, some tens of millions of patients in the U.S. suffer from dermatologic conditions for which they do not seek treatment from a qualified provider. Now, USA-based innovator in the dermatology space and the original source for FDA Regulated customized skin medicines, Prescriber’s Choice, wants to change that with a new platform giving “Choice” to both the patients and the providers, all the while putting the doctor-patient relationship at the center of it all.
Prescriber’s Choice is gearing up to kick off a digital complement to its custom medicine offering, the “Choice Derm Locator”, that will empower patients to find a “Choice Derm” to support their dermatologic needs and give providers the opportunity to see patients in the manner they feel is best and most efficient, in a frictionless, efficient environment, and the “Choice” to provide custom medicines.
We spoke to the co-founder and CEO, Dr. Spencer Malkin, to get a sneak peek at what Prescriber’s Choice has in store next: “Our past six years of growth have always been built on our relationship with dermatology providers nationwide. Educating new patients about their practices is the ultimate next step in our growth together. The Choice Derm Locator will be what puts all of these pieces together for us and our dermatology partners.”
On the patient side, the “Choice Derm Locator” will offer patients the “Choice” to find and select a qualified dermatology specialist based on criteria that meets their needs, including the type of visit and customized medicine offering. According to Dr. Malkin, “our data shows that patients appreciate the importance of working with their prescriber to receive customized, accessible, and affordable medicines.” In fact, Prescriber’s Choice reports that nearly 9 in 10 patients have indicated that they would prefer to receive custom medicines directly from their prescriber. Dr. Malkin also noted “the enormous size of the total addressable marketplace of people that suffer from dermatological disorders, but that don’t see a dermatologist. Our goal is to bridge that gap.”
On the prescriber side, providers will have the “Choice” to see their patients in the manner they feel is best and access to a full library of customized medications. The Choice Derm program will soon take physician requests for registration and will be live for patients in the coming months. Dermatology specialists can opt in to become identified as Choice Derm providers, which will include Choice Derm accreditation and support. Dr. Malkin emphasized that “the critical piece here is that patients are building a true relationship with their prescriber. Rather than being limited to mass-produced treatments that are often dictated and contracted by payers and may be problematic for some patients, providers and patients can choose to receive custom medicines suitable for them. The prescriber-patient relationship that is so central to patient health, which is lost with many online medicine access portals, helps ensure the continuum of care that supports patient health.”
Prescriber’s Choice is used to path-breaking innovations, currently offering over 120 different drug combinations, all of which are manufactured in an FDA-registered 503B outsourcing facility to treat over a dozen dermatologic conditions (like acne, rosacea, melasma and hair loss). These formulas are backed by unique customizations by dermatological providers who remove common allergens and irritants, adjust dosage forms and potencies, and then combine multiple ingredients to deliver a tailored pharmaceutical solution for their patients. Prescriber’s Choice allows dermatologists to dispense these medications to patients at the time and place of their office visit, and likewise implementing the technology to ship prescriptions directly to a patient’s home.
In preparation for the Choice Derm launch, last month the company announced the expansion of their facility in Florida, with an additional state-of-the-art manufacturing facility to meet the growing demand.
“As a society we have moved past a one-size-fits-all lifestyle, and technology has made it so we are better able to meet people’s needs,” said Dr. Malkin, “We have brought this same mindset to dermatology with a focus on supporting the prescriber-patient relationship and to ensure quality for every patient. All patients deserve a Choice, and Prescriber’s Choice is committed to helping them find their Choice Derm.”
Yet another revolutionary service, pandemic-born telehealth clinic Tripstitterer, has begun serving the American community throughout this public health-crisis. As lockdown restrictions brought on by the global covid-19 pandemic forced people away from their daily routines and into their homes, this unavoidable isolation had profound effects on society’s mental health, increasing reported depression and anxiety from 11 percent of the population up to a staggering 41.1 percent in less than a year’s time. Looking to help offset this startling trend, Tripsitter has established itself at the forefront of the burgeoning psychedelic treatment space, helping aid people through these struggles from the comfort of their very own homes.
Though traditional treatments for depression, like SSRIs, function for some, many users report adverse side effects like feeling emotionally numb and unlike themselves, leading to many seeking alternative treatments outside of pharmaceuticals. That’s where medically prescribed ketamine comes in, offering a relief to serious symptoms of depression and anxiety, including vitally reducing life-threatening thoughts and suicidal behaviors. Still, though legalized across the entirety of the United States, many of those struggling with mental health issues are unaware of ketamine as a viable choice to alleviate their struggles, or live too far away to access a brick-and-mortar clinic to receive a ketamine infusion.
This is where Tripsitter comes in; by setting up virtual consultations with licensed physicians across the country, Tripsitter gives the opportunity for people with diagnosed mental health issues to quickly attain a prescription for orally administered ketamine online, delivered directly to their front door. While ketamine therapy has traditionally been used in outpatient clinics, only allowing those living in close proximity to access the treatment, Tripsetter has changed the game by providing full accessibility to anyone with internet access throughout 15 U.S. states, with the full nationwide service planned for implementation within the next 90 days.
The platform likewise pairs patients with designated ‘tripsitters,’ who help newcomers to ketamine therapy navigate the treatment and create the perfect environment to make it as effective and seamless as possible. With plans on branching into other psychedelics like MDMA and psilocybin as in tandem with their eventual medicinal legalization, Tripsitter has cemented itself firmly at the forefront of the still-emerging psychedelic treatment therapy space.
As ground-breaking healthcare leaders like Prescriber’s Choice and Tripsitter continue to make waves across the landscape of American medical care, the duo’s virtual innovations are set to make quality care more accessible, attainable, and affordable for all, changing the trajectory of the healthcare sector forever.Internet Explorer Channel Network